Giorgio Sirugo
Research Subjects
Research Interests
Giorgio Sirugo has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
A Worwui
MRC laboratories, Banjul, The Gambia
1 shared publicationAlieu Mendy
Medical Research Council Laboratories, Fajara and Farafenni, The Gambia, West Africa
1 shared publicationBeryl West
Medical Research Council Laboratories, Fajara and Farafenni, The Gambia, West Africa
1 shared publication- Christian Wejse
Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
1 shared publication - Cyrille Bisseye
Department of Biology, Faculty of Sciences, University of Science and Technology of Masuku, Franceville P.O. Box 943, Gabon
1 shared publication D R Velez
MRC laboratories, Banjul, The Gambia
1 shared publication
Latest Publications
- 5 July 2007
- Published by Springer Nature in Genes & Immunity
- Vol. 8 (6) , 456-467
DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans
We investigated the role of DC-SIGN (CD209), long pentraxin 3 (PTX3) and vitamin D receptor (VDR) gene single nucleotide polymorphisms (SNPs) in susceptibility to pulmonary tuberculosis (TB) in 321 TB cases and 347 healthy controls from Guinea-Bissau. Five additional, functionally relevant SNPs within toll-like receptors (TLRs) 2, 4 and 9 were typed but found, when polymorphic, not to affect host vulnerability to pulmonary TB. We did not replicate an association between SNPs in the DC-SIGN promoter and TB. However, we found that two polymorphisms, one in DC-SIGN and one in VDR, were associated in a nonadditive model with disease risk when analyzed in combination with ethnicity (P=0.03 for DC-SIGN and P=0.003 for VDR). In addition, PTX3 haplotype frequencies significantly differed in cases compared to controls and a protective effect was found in association with a specific haplotype (OR 0.78, 95% CI 0.63–0.98). Our findings support previous data showing that VDR SNPs modulate the risk for TB in West Africans and suggest that variation within DC-SIGN and PTX3 also affect the disease outcome.
- 5 July 2007
- Published by Springer Nature in Genes & Immunity
- Vol. 8 (6) , 456-467
DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans
We investigated the role of DC-SIGN (CD209), long pentraxin 3 (PTX3) and vitamin D receptor (VDR) gene single nucleotide polymorphisms (SNPs) in susceptibility to pulmonary tuberculosis (TB) in 321 TB cases and 347 healthy controls from Guinea-Bissau. Five additional, functionally relevant SNPs within toll-like receptors (TLRs) 2, 4 and 9 were typed but found, when polymorphic, not to affect host vulnerability to pulmonary TB. We did not replicate an association between SNPs in the DC-SIGN promoter and TB. However, we found that two polymorphisms, one in DC-SIGN and one in VDR, were associated in a nonadditive model with disease risk when analyzed in combination with ethnicity (P=0.03 for DC-SIGN and P=0.003 for VDR). In addition, PTX3 haplotype frequencies significantly differed in cases compared to controls and a protective effect was found in association with a specific haplotype (OR 0.78, 95% CI 0.63–0.98). Our findings support previous data showing that VDR SNPs modulate the risk for TB in West Africans and suggest that variation within DC-SIGN and PTX3 also affect the disease outcome.
- 21 April 2004
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 128A (1) , 104-105
Is G6PD A‐ deficiency associated with recurrent stillbirths in The Gambia?
- 21 April 2004
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 128A (1) , 104-105
Is G6PD A‐ deficiency associated with recurrent stillbirths in The Gambia?